ISCHEMIA-Chronic Kidney Disease Trial | stella

Learn Data For Researchers Find trials matched to me

Learn Data For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ISCHEMIA-Chronic Kidney Disease Trial | stella

Back to Cardiovascular Diseases trials

Completed

Plain-English translation of NCT01985360 on ClinicalTrials.gov ↗ · Source last updated October 2021 · How we translate trials

Read our Coronary artery disease research guide →

Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.

Trial locations(1 site)

United States

NYU Langone Medical Center, New York, New York

Results

Read the full plain-English summary of this trial →

Key details

Phase

Post-approval monitoring

Sponsor

NYU Langone Health

Collaborators

New York University, National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~777 participants

Started

January 2014

Primary completion

June 2019

Age range

21 Years and older

Last updated on clinicaltrials.gov in October 2021.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov